Yanzhen Cheng

748 total citations
22 papers, 578 citations indexed

About

Yanzhen Cheng is a scholar working on Molecular Biology, Epidemiology and Surgery. According to data from OpenAlex, Yanzhen Cheng has authored 22 papers receiving a total of 578 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 9 papers in Epidemiology and 6 papers in Surgery. Recurrent topics in Yanzhen Cheng's work include Pancreatic function and diabetes (5 papers), Liver Disease Diagnosis and Treatment (4 papers) and Autophagy in Disease and Therapy (4 papers). Yanzhen Cheng is often cited by papers focused on Pancreatic function and diabetes (5 papers), Liver Disease Diagnosis and Treatment (4 papers) and Autophagy in Disease and Therapy (4 papers). Yanzhen Cheng collaborates with scholars based in China and Hong Kong. Yanzhen Cheng's co-authors include Li Yang, Hua Zhang, Shitao Rao, Qinghua Li, Yang Li, Peng Liu, Min Ho An, Ningning Xu, Lishan Li and Wen Xu and has published in prestigious journals such as PLoS ONE, Life Sciences and American Journal of Physiology-Endocrinology and Metabolism.

In The Last Decade

Yanzhen Cheng

22 papers receiving 571 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yanzhen Cheng China 14 238 165 157 149 83 22 578
Stefano Ministrini Italy 16 187 0.8× 188 1.1× 134 0.9× 160 1.1× 208 2.5× 59 846
Markus Trieb Austria 14 147 0.6× 107 0.6× 188 1.2× 170 1.1× 127 1.5× 16 629
Urszula Raźny Poland 14 262 1.1× 122 0.7× 114 0.7× 73 0.5× 202 2.4× 36 656
Mieczysław Dutka Poland 10 262 1.1× 73 0.4× 103 0.7× 100 0.7× 50 0.6× 21 602
Carla Ferri Spain 14 166 0.7× 101 0.6× 134 0.9× 110 0.7× 36 0.4× 33 691
Shinji Tabata Japan 16 107 0.4× 128 0.8× 136 0.9× 69 0.5× 132 1.6× 23 677
Yu Tsushima Japan 9 201 0.8× 236 1.4× 81 0.5× 69 0.5× 133 1.6× 14 601
Christos Kalofoutis Greece 9 135 0.6× 116 0.7× 183 1.2× 79 0.5× 93 1.1× 18 522
Seok Man Son South Korea 15 162 0.7× 189 1.1× 246 1.6× 103 0.7× 243 2.9× 43 821

Countries citing papers authored by Yanzhen Cheng

Since Specialization
Citations

This map shows the geographic impact of Yanzhen Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanzhen Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanzhen Cheng more than expected).

Fields of papers citing papers by Yanzhen Cheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yanzhen Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanzhen Cheng. The network helps show where Yanzhen Cheng may publish in the future.

Co-authorship network of co-authors of Yanzhen Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Yanzhen Cheng. A scholar is included among the top collaborators of Yanzhen Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanzhen Cheng. Yanzhen Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Luo, Ming‐Jiu, Fenfen Peng, Meihua Zhang, et al.. (2025). Sodium-glucose cotransporter 2 inhibitors alleviate renal fibrosis in diabetic kidney disease by inhibiting Hmgcs2 and Btg2 in proximal tubular cells. Journal of Translational Medicine. 23(1). 959–959. 1 indexed citations
2.
3.
Chen, Huafeng, et al.. (2024). Network analysis and experimental verification of Salvia miltiorrhiza Bunge-Reynoutria japonica Houtt. drug pair in the treatment of non-alcoholic fatty liver disease. BMC Complementary Medicine and Therapies. 24(1). 305–305. 2 indexed citations
4.
Yang, Li, et al.. (2024). Electronic Interactive Games for Glycemic Control in Individuals With Diabetes: Systematic Review and Meta-Analysis. JMIR Serious Games. 12. e43574–e43574. 4 indexed citations
5.
Wang, Lin, et al.. (2022). Facile chemoenzymatic synthesis of unmodified anticoagulant ultra-low molecular weight heparin. Organic & Biomolecular Chemistry. 20(42). 8323–8330. 4 indexed citations
6.
Cheng, Yanzhen, Peng Liu, Jiamin Liang, et al.. (2022). Glucagon-like peptide-1 attenuates diabetes-associated osteoporosis in ZDF rat, possibly through the RAGE pathway. BMC Musculoskeletal Disorders. 23(1). 465–465. 27 indexed citations
7.
Zhou, Rui, Yanzhen Cheng, Qinghua Li, et al.. (2021). Liraglutide Alleviates Hepatic Steatosis and Liver Injury in T2MD Rats via a GLP-1R Dependent AMPK Pathway. Frontiers in Pharmacology. 11. 600175–600175. 31 indexed citations
8.
An, Min Ho, et al.. (2021). Effect of Acid or Base Interventions on Bone Health: A Systematic Review, Meta-Analysis, and Meta-Regression. Advances in Nutrition. 12(4). 1540–1557. 9 indexed citations
9.
Li, Qinghua, Wenbin Huang, Yibing Han, et al.. (2021). Dapagliflozin Alleviates Hepatic Steatosis by Restoring Autophagy via the AMPK-mTOR Pathway. Frontiers in Pharmacology. 12. 589273–589273. 86 indexed citations
10.
Guo, Bo, et al.. (2021). LncRNA HOTAIR regulates the lipid accumulation in non-alcoholic fatty liver disease via miR-130b-3p/ROCK1 axis. Cellular Signalling. 90. 110190–110190. 28 indexed citations
11.
Rao, Shitao, et al.. (2020). Glucagon-like peptide-1 alleviates diabetic kidney disease through activation of autophagy by regulating AMP-activated protein kinase-mammalian target of rapamycin pathway. American Journal of Physiology-Endocrinology and Metabolism. 319(6). E1019–E1030. 44 indexed citations
12.
Wang, Ji‐Yu, et al.. (2019). Dapagliflozin Attenuates Hyperglycemia Related Osteoporosis in ZDF Rats by Alleviating Hypercalciuria. Frontiers in Endocrinology. 10. 700–700. 16 indexed citations
13.
Zhou, Rui, et al.. (2019). Liraglutide Alleviates Hepatic Steatosis and Liver Injury in T2MD Rats via a GLP-1R Dependent AMPK Pathway. SSRN Electronic Journal. 4 indexed citations
14.
Cheng, Yanzhen, Ji‐Yu Wang, Litao Wang, et al.. (2018). Irbesartan attenuates advanced glycation end products-mediated damage in diabetes-associated osteoporosis through the AGEs/RAGE pathway. Life Sciences. 205. 184–192. 46 indexed citations
15.
Zhang, Ya, Yuanna Ling, Li Yang, et al.. (2017). Liraglutide relieves myocardial damage by promoting autophagy via AMPK-mTOR signaling pathway in zucker diabetic fatty rat. Molecular and Cellular Endocrinology. 448. 98–107. 68 indexed citations
16.
17.
Yang, Li, et al.. (2016). Interleukin-22 Alleviated Palmitate-Induced Endoplasmic Reticulum Stress in INS-1 Cells through Activation of Autophagy. PLoS ONE. 11(1). e0146818–e0146818. 26 indexed citations
18.
Cheng, Yanzhen, Zefeng Shen, Jiaxin Peng, et al.. (2016). ACE inhibitors and the risk of fractures: a meta-analysis of observational studies. Endocrine. 55(3). 732–740. 13 indexed citations
19.
Cheng, Yanzhen, Hua Zhang, Rongping Chen, et al.. (2014). Cardiometabolic Risk Profiles Associated with Chronic Complications in Overweight and Obese Type 2 Diabetes Patients in South China. PLoS ONE. 9(7). e101289–e101289. 15 indexed citations
20.
Sun, Nan, et al.. (2013). [Advanced oxidation protein products inhibit proliferation and differentiation of rat osteoblasts through oxidative stress].. PubMed. 33(3). 356–9. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stefano Ministrini Breakdown of academic impact, for papers by Markus Trieb Breakdown of academic impact, for papers by Urszula Raźny Breakdown of academic impact, for papers by Mieczysław Dutka Breakdown of academic impact, for papers by Carla Ferri Breakdown of academic impact, for papers by Shinji Tabata Breakdown of academic impact, for papers by Yu Tsushima Breakdown of academic impact, for papers by Christos Kalofoutis Breakdown of academic impact, for papers by Seok Man Son
Rankless by CCL
2026